Company: LGN
Filing Date: 2025-07-15
Form Type: DRS/A
Source: 0000950123-25-006399
Chunk: 102

Company: Legence Corp.
Filing Date: 2025-07-15
Form: DRS/A
Chunk 102
---
 200.83

from this offering, after deducting the underwriting discounts and commissions and estimated offering expenses, received by us to change by $ million, assuming the
initial public offering price of $ per share, which is the midpoint of the estimated public offering price range set forth on the cover of this prospectus, remains the same. The information discussed above is illustrative
only and will adjust based on the actual initial public offering price and other terms of this offering determined at the time of the pricing of this offering.

63

Confidential Treatment Requested by Legence Corp.

Pursuant to 17 C.F.R. Section 200.83

DIVIDEND POLICY

Following the completion of this offering, our board of directors may elect to declare cash dividends on our Class A Common Stock,
subject to our compliance with applicable law, and depending on, among other things, economic conditions, our financial condition, results of operations, projections, liquidity, earnings, legal requirements and restrictions in the agreements
governing our indebtedness (as further discussed below). The payment of any future dividends will be at the discretion of our board of directors. We have not adopted, and do not currently expect to adopt, a written dividend policy.

The Credit Agreement contains restrictions on the payment of dividends. Such restrictions allow us to pay dividends after the completion of
this offering only when certain conditions are met, including but not limited to compliance with certain dollar baskets, ratio tests and the absence of certain specified events of default. See the section entitled “Management’s Discussion
and Analysis of Financial Condition and Results of Operations—Liquidity and Capital Resources—Debt.”

See “Risk
Factors—Risks Related to Our Class A Common Stock and Structure— We do not intend to pay dividends following the completion of this offering and may never pay dividends” and “Management’s Discussion and Analysis of
Financial Condition and Results of Operations—Liquidity and Capital Resources.”

64

Confidential Treatment Requested by Legence Corp. Pursuant to 17 C.F.R. Section 200.83 CAPITALIZATION The following table sets forth our cash position and capitalization as of March 31, 2025:

| • |     | on an actual basis for our predecessor; and |

| • |     | on an as adjusted basis to give effect to the reorganization described under “Corporate Reorganization”                                                                                                                           
 and this share offering at an assumed initial public offering price of $    per share (the midpoint of